Article
KRAS gene mutations in correlation with clinicopathological features of colorectal carcinomas in Indian patient cohort.
Medical oncology (Northwood, London, England) - 1 Jan 2013
Patil Harshali, Korde Rajesh, Kapat Arnab
Abstract excerpt
KRAS gene mutations have been identified as a predictive molecular marker to predict the sensitivity of tumors to anti-EGFR therapeutics. The variability of clinical response to anti-EGFR agents has highlighted the need to select the appropriate patients who can benefit from the treatment. We exa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
